3 February 2021 SPONSORED

Biosimilars Spondyloarthritis

FURTHER YOUR EDUCATION WITH SANDOZ IN 2021

27 January 2021

Virtual exercise programs can beat the COVID blues

15 December 2020

Conditions COVID-19 Telehealth

How rheumatology changed in 2020

3 December 2020

Analgesics Conditions Spondyloarthritis

Battle of the monotherapies: etanercept vs methotrexate

4 November 2020

Analgesics Conditions Pharmacy Guild of Australia

COVID or giant cell arteritis: how to spot the difference

4 November 2020

Analgesics Conditions Pain

Post-surgery pain and trusting biosimilars

22 September 2020

Conditions

IL-17 inhibitor appears safe and effective for nr-axSpA

10 August 2020

Rheuma referrals cancelled due to COVID

28 July 2020

Pain

Pain campaign helps patients both manage and talk about it

15 July 2020

Conditions Technology

TGA approves Ixekizumab for AS

5 June 2020

Analgesics Conditions Spondyloarthritis

Opioid use for rheuma pain rising, warn European experts

28 May 2020

Conditions

Case study: cyclist with bilateral pain in buttocks

28 May 2020

Spondyloarthritis

MyRA website personalises information for each patient

26 March 2020

APLAR Conditions

Rheuma drugs co-opted in fight against COVID-19

11 March 2020

APLAR

Immunocompromised patients worried about COVID-19